Literature DB >> 27470250

Echo color Doppler ultrasound: a valuable diagnostic tool in the assessment of arteriovenous fistula in hemodialysis patients.

Anna Mudoni1, Francesco Caccetta1, Maurizio Caroppo1, Fernando Musio1, Antonella Accogli1, Maria Dolores Zacheo1, Maria Domenica Burzo1, Maurizio Gallieni2,3, Vitale Nuzzo1.   

Abstract

A functioning vascular access is a critical requirement to improve the quality of life in hemodialysis patients, so monitoring and surveillance of vascular access play key roles in identifying all dysfunctions and reducing the huge economic cost as well as adequacy of dialysis.In our five-year experience, a study protocol has been used and improved with the help of ultrasonography.Doppler ultrasound is an excellent and sensitive modality for hemodialysis access evaluation, one of techniques employed for arteriovenous fistulae (AVF) study, not only as a preoperative tool, but also in post-operative monitoring of AVF maturation. In addition, the current guidelines recommend AVF surveillance by access blood flow measurement and the correction of hemodynamic stenosis in order to prolong access survival. Doppler ultrasound is readily available, directly used by nephrologists, non-invasive, safe, inexpensive, reproducible, although it requires more clinical skill and time to perform and proper equipment. Ultrasonography imaging can substantially reduce the number of subsequent invasive angiographic procedures. In our opinion, Doppler ultrasound should have a crucial place in the interdisciplinary cooperation in AVF monitoring and it should be included as part of an integrated vascular access management program.

Entities:  

Mesh:

Year:  2016        PMID: 27470250     DOI: 10.5301/jva.5000588

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  7 in total

1.  Effect of Arteriovenous Fistula Creation on Systolic and Diastolic Blood Pressure in Patients With Pre-dialysis Advanced Chronic Kidney Disease.

Authors:  Roy O Mathew; Jerome Fleg; Janani Rangaswami; Bo Cai; Arif Asif; Mandeep S Sidhu; Sripal Bangalore
Journal:  Am J Hypertens       Date:  2019-08-14       Impact factor: 2.689

2.  Ultrasound dilution and thermodilution versus color Doppler ultrasound for arteriovenous fistula assessment in children on hemodialysis.

Authors:  Vasiliki Karava; Theresa Kwon; Gilbert Franco; Deschenes Georges; Marie-Alice Macher; Julien Hogan
Journal:  Pediatr Nephrol       Date:  2019-07-19       Impact factor: 3.714

3.  Plasmatic osteopontin and vascular access dysfunction in hemodialysis patients: a cross-sectional, case-control study (The OSMOSIS Study).

Authors:  Julie Contenti; Matthieu Durand; Sandor Vido; Serge Declemy; Juliette Raffort; Joseph Carboni; Sophie Bonnet; Christophe Koelsch; Réda Hassen-Khodja; Philippe Gual; Nathalie M Mazure; Nirvana Sadaghianloo
Journal:  J Nephrol       Date:  2021-09-01       Impact factor: 3.902

4.  Integrated management to reduce fistula-related long-term complications and improve the quality of life after arteriovenous fistula surgery: A retrospective cohort study.

Authors:  Min Ning; Dan Luo; Gang Ye; Ting Zhang; Li Liu; Fumei Peng
Journal:  Nurs Open       Date:  2021-03-04

5.  The influence of a doppler ultrasound in arteriovenous fistula for dialysis failure related to some risk factors.

Authors:  Jocefábia Reika Alves Lopes; Ana Lígia de Barros Marques; João Antonio Correa
Journal:  J Bras Nefrol       Date:  2020-04-27

6.  Lung Congestion Severity in Kidney Transplant Recipients Is Not Affected by Arteriovenous Fistula Function.

Authors:  Krzysztof Letachowicz; Anna Królicka; Andrzej Tukiendorf; Mirosław Banasik; Dorota Kamińska; Tomasz Gołębiowski; Magdalena Kuriata-Kordek; Katarzyna Madziarska; Oktawia Mazanowska; Magdalena Krajewska
Journal:  J Clin Med       Date:  2022-02-05       Impact factor: 4.241

7.  Randomised clinical study of the impact of routine preoperative Doppler ultrasound for the outcome of autologous arteriovenous fistulas for haemodialysis.

Authors:  Jocefábia Reika Alves Lopes; Ana Lígia de Barros Marques; João Antonio Correa
Journal:  J Vasc Access       Date:  2020-06-10       Impact factor: 2.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.